Graft vs. host disease after liver transplantation: A new approach is needed

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Liver transplantation

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lt.21203PMID 17663410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use

  2007cited by this paper
• Use of Short Tandem Repeats for DNA Fingerprinting to Rapidly Diagnose Graft-versus-Host Disease in Solid Organ Transplant Patients

  2006cited by this paper
• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  2006influential reference
• Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation.

  2005cited by this paper
• Acute Graft versus Host Disease After Liver Transplantation: Patterns of Lymphocyte Chimerism

  2005influential reference
• Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis.

  2005cited by this paper
• Acute Graft Versus Host Disease Following Liver Transplantation: The Enemy Within

  2004cited by this paper
• Lichenoid graft vs. host disease following liver transplantation

  2004cited by this paper
• Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graftversus-host disease after liver transplantation

  2004cited by this paper
• Graft‐versus‐host disease following living donor liver transplantation

  2004cited by this paper
• Control Of Organ Transplant-Associated Graft-versus-Host Disease By Activated Host Lymphocyte Infusions

  2004cited by this paper
• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

  2004influential reference
• Liver transplant-associated graft-versus-host disease

  2003influential reference
• Graft-vs-host disease after solid organ transplant.

  2003cited by this paper
• Treatment of Graft‐Versus‐Host Disease After Liver Transplantation with Basiliximab Followed by Bowel Resection

  2003influential reference
• Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease.

  2002influential reference
• Confirmation of graft-versus-host disease by HLA typing after liver transplantation.

  2002cited by this paper
• Transfusion‐associated graft‐versus‐host disease

  2002cited by this paper
• Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression.

  2002cited by this paper
• Transfusion-associated graft versus host disease

  2002cited by this paper
• Graft-Versus-Host Disease in Solid Organ Transplantation

  2001cited by this paper
• Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin

  2001cited by this paper
• Late onset of severe graft-versus-host disease in a pediatric liver transplant recipient.

  2001cited by this paper
• Rapid method for the analysis of peripheral chimerism in suspected graft‐versus‐host disease after liver transplantation

  2000cited by this paper
• Graft‐versus‐host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing

  2000cited by this paper
• Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis.

  2000cited by this paper
• Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease with Rabbit Antithymocyte Globulin

  2000cited by this paper
• PCR confirmation of microchimerism and diagnosis of Graft versus Host Disease after liver transplantation

  1999cited by this paper
• Cutaneous lesions as the presenting sign of acute graft‐versus‐host disease following liver transplantation

  1999cited by this paper
• Unusual presentation of graft‐versus‐host disease in pediatric liver transplant recipients: Evidence of late and recurrent disease

  1999cited by this paper
• Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood.

  1998cited by this paper
• Successful treatment of graft-vs-host disease after a second liver transplant.

  1998cited by this paper
• One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation

  1998cited by this paper
• Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes.

  1998influential reference
• One‐way donor‐recipient HLA‐matching as a risk factor for graft‐versus‐host disease in living‐related liver transplantation

  1998cited by this paper
• Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor.

  1996cited by this paper
• Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: report of a case and literature review.

  1996cited by this paper
• Morbilliform eruption in a liver transplantation patient.

  1996cited by this paper
• Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient.

  1996cited by this paper
• Lethal acute graft‐versus‐host disease in a liver transplant recipient: Relations with cell migration and chimerism

  1995cited by this paper
• Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease.

  1995cited by this paper
• Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation.

  1994cited by this paper
• Survival of graft-versus-host disease in a liver transplant recipient.

  1994cited by this paper
• Reversal of Graft-Versus-Host Disease with Infusion of Autologous Bone Marrow

  1994cited by this paper
• Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance

  1993cited by this paper
• Graft-versus-host disease after liver transplantation.

  1993cited by this paper
• Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing.

  1993cited by this paper
• Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient.

  1993cited by this paper
• Clinical and pathological features of graft‐versus‐host disease after liver transplantation: A case report and review of the literature

  1993cited by this paper
• Graft-versus-Host Disease in a Liver Transplant Recipient

  1992cited by this paper
• Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation.

  1992cited by this paper
• Lymphocyte chimaerism after organ transplantation.

  1992cited by this paper
• Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy.

  1992cited by this paper
• Graft vs. host disease after liver transplantation in humans: A report of four cases

  1991cited by this paper
• Graft-versus-host disease in solid organ transplantation

  1991cited by this paper
• A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.

  1990cited by this paper
• Fatal generalized acute graft-versus-host disease in a liver transplant recipient.

  1990cited by this paper
• A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.

  1990cited by this paper
• Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis.

  1990cited by this paper
• A PHASE I‐II STUDY EVALUATING THE MURINE ANTI‐IL-2 RECEPTOR ANTIBODY 2A3 FOR TREATMENT OF ACUTE GRAFT‐VERSUS-HOST DISEASE

  1990cited by this paper
• Transfusion-associated graft-versus-host disease.

  1990cited by this paper
• Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10)

  1990cited by this paper
• Graft-versus-host disease after orthotopic liver transplantation in a child.

  1990cited by this paper
• Severe graft-versus-host disease in a liver-transplant recipient.

  1988cited by this paper
• Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone.

  1985cited by this paper
• Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids

  1981cited by this paper
• The biology of graft-versus-host reactions.

  1966cited by this paper
• The biology of graft-versus-host reactions.

  1966cited by this paper
• Transfusion or transplantation

  1965cited by this paper
• Transfusion or transplantation?

  1965cited by this paper

• Graft-versus-host disease after liver transplantation: A global review of pathogenesis, diagnosis, and treatment strategies.

  2025cites this paper
• Stevens–Johnson syndrome/toxic epidermal necrolysis in an orthotopic liver transplant recipient: a case report

  2024influential citation
• Incidence and risk factors of graft-versus-host disease after liver transplantation: A national study 2010–2020

  2023cites this paper
• One-way donor-to-recipient human leukocyte antigen mismatch and graft-versus-host disease in liver transplantation: an observational study of a single-center experience in Korea

  2023cites this paper
• Detecting Donor-Derived DNA by Real-Time PCR in Recipients Suspected of Graft-Versus-Host-Diseases After Liver Transplantation: A Case Series and Literature Review

  2023cites this paper
• Basic Understanding of Liver Transplant Immunology.

  2023cites this paper
• Development of graft-versus-host disease in a liver recipient. Clinical observations and literature review

  2023cites this paper
• JAK Inhibitors in Solid Organ Transplantation

  2023cites this paper
• Graft-versus-host disease following liver transplantation: A systematic review of literature

  2023influential citation
• HTLV-1 infection of donor-derived T cells might promote acute graft-versus-host disease following liver transplantation

  2022cites this paper
• Graft-Versus-Host Disease in Pediatric Living Donor Liver Transplant.

  2022cites this paper
• Diagnostic and therapeutic dilemma in Stevens–Johnson syndrome-like acute graft-versus-host disease after liver transplantation: A case report

  2022cites this paper
• Graft versus host disease after liver transplantation following radiotherapy for the treatment of hepatocellular carcinoma: A case report and literature review

  2022cites this paper
• CAQ Corner: Immune‐mediated complications

  2022cites this paper
• How we diagnose and treat acute graft-versus-host disease after solid organ transplantation.

  2022cites this paper
• Graft‐versus‐host disease after pediatric liver transplantation: A diagnostic challenge

  2021cites this paper
• Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients

  2021cites this paper
• Post-liver transplantation GVHD: time to consider histocompatibility testing

  2021cites this paper
• Lymphohematopoietic graft-versus-host responses promote mixed chimerism in patients receiving intestinal transplantation.

  2021cites this paper
• Fluorescence in situ hybridization-based confirmation of acute graft-vs-host disease diagnosis following liver transplantation: A case report

  2021cites this paper
• Graft‐versus‐host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations

  2021cites this paper
• Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report

  2021cites this paper
• Early Outcomes of Ruxolitinib in the Treatment of Steroid Refractory Graft-versus-host Disease on Liver Transplant Recipients.

  2020cites this paper
• Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: A report of 11cases.

  2020cites this paper
• Donor‐targeted serotherapy as a rescue therapy for steroid‐resistant acute GVHD after HLA‐mismatched kidney transplantation

  2020cites this paper
• Etiology Based Sickle Cell Disease Hepatopathy

  2020cites this paper
• WITHDRAWN: Immunomodulatory effects of sCD83 via induction of TGF-β1 and IDO: an in vitro and rat orthotopic liver transplantation study

  2020cites this paper
• Graft-Versus-Host Disease

  2019cites this paper
• An enigmatic case of undiagnosed severe diarrhoea post living donor liver transplant.

  2019cites this paper
• Cenicriviroc ameliorates the severity of graft-versus-host disease through inhibition of CCR5 in a rat model of liver transplantation.

  2019cites this paper
• Acute Graft-vs-Host Disease After Liver Transplantation in a Patient Presenting With Neurogenic Symptoms as the Single Primary Manifestation: A Case Report.

  2018cites this paper
• Detecting chimerism contributes to diagnosis of graft versus host disease after orthotopic liver transplantation.

  2018cites this paper
• Improved survival after LTx‐associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single‐center experience and systematic review

  2018cites this paper
• transplantation: a case report and a review of literature

  2018cites this paper
• Graft‐versus‐host disease of the central nervous system after liver transplantation: A rare complication

  2018cites this paper
• Novel Application of Extracorporeal Photopheresis as Treatment of Graft-versus-Host Disease Following Liver Transplantation

  2017cites this paper
• Donors With Immune Thrombocytopenia: Do They Pose a Risk to Transplant Recipients?

  2017cites this paper
• Graft‐Versus‐Host Disease Following Liver Transplantation: Development of a High‐Incidence Rat Model and a Selective Prevention Method

  2017cites this paper
• Lichenoid Graft-vs-Host Disease With Exclusively Cutaneous Involvement After Liver Transplant (cid:2) Restoration of Response to Ustekinumab With Narrowband UV-B Phototherapy

  2017cites this paper
• Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management

  2016cites this paper
• Tropheryma whipplei infection (Whipple's disease) in a patient after liver transplantation

  2016cites this paper
• Graft-versus-host Disease After Intestinal or Multivisceral Transplantation: A Scandinavian Single-center Experience.

  2016cites this paper
• Acute Graft-vs-Host Disease After Liver Transplantation: Experience at a High-volume Liver Transplantation Center in Korea.

  2016cites this paper
• Immunological basis for treatment of graft versus host disease after liver transplant

  2016cites this paper
• Management of immunosuppressant agents following liver transplantation: Less is more.

  2016cites this paper
• Enfermedad injerto contra huésped liquenoide tras trasplante hepático con afectación exclusivamente cutánea Lichenoid Graft-vs-Host Disease With Exclusively Cutaneous Involvement After Liver Transplant

  2016cites this paper
• Successful salvage treatment of acute graft-versus-host disease after liver transplantation by withdrawal of immunosuppression: a case report

  2016cites this paper
• Enfermedad de injerto contra huésped en trasplante de órgano sólido

  2015influential citation
• Graft-versus-Host Disease after Liver Transplantation: A Single-Center Case Series.

  2015cites this paper
• Graft‐versus‐host disease after orthotopic liver transplantation: multivariate analysis of risk factors

  2015cites this paper
• Absence of peripheral blood chimerism in graft‐vs‐host disease following orthotopic liver transplantation: case report and review of the literature

  2014cites this paper
• Lichenoid graft-vs-host disease with exclusively cutaneous involvement after liver transplant.

  2014cites this paper
• Abatacept use in graft-versus-host disease after orthotopic liver transplantation: a case report.

  2014cites this paper
• Lichenoid graft-vs-host disease with exclusively cutaneous involvement after liver transplant.

  2014cites this paper
• Diarrhea in solid-organ transplant recipients: a review of the evidence

  2013cites this paper
• Forma aguda da doença enxerto contra o hospedeiro após transplante de fígado. Existe opção terapêutica para as formas refratárias ao tratamento com esteróides

  2012cites this paper
• Acute graft versus host disease after orthotopic liver transplantation

  2012cites this paper
• Graft-versus-host disease after liver transplantation: a comprehensive literature review.

  2012cites this paper
• Chronic graft-versus-host disease after liver transplantation: a case report.

  2012cites this paper
• Relevance of HLA compatibility in living donor liver transplantation: the double‐edged sword associated with the patient outcome

  2012cites this paper
• Development of a new quantitative real-time HHV-6-PCR and monitoring of HHV-6 DNAaemia after liver transplantation.

  2012cites this paper
• Treatment of liver transplant graft-versus-host disease with antibodies against tumor necrosis factor-α.

  2012cites this paper
• Korean red ginseng: a new approach for the treatment of graft-versus-host disease after liver transplantation.

  2011cites this paper
• Incidence of acute and chronic graft-versus-host disease and donor T-cell chimerism after small bowel or combined organ transplantation.

  2011cites this paper
• Haploidentical hematopoietic stem cell transplantation for graft-versus-host disease after liver transplantation.

  2011cites this paper
• Correlation of Chimerism with Acute Graft-versus-Host Disease in Rats following Liver Transplantation

  2011cites this paper
• Long-term clinical outcome after liver transplantation

  2010cites this paper
• Long-term clinical outcome after liver transplantation

  2010cites this paper
• Solid organ transplant-associated acute graft-versus-host disease.

  2010cites this paper
• Acute graft‐versus‐host disease after liver transplant: Novel use of etanercept and the role of tumor necrosis factor α inhibitors

  2009cites this paper
• Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.

  2009cites this paper
• Infliximab treatment for steroid‐refractory acute graft‐versus‐host disease after orthotopic liver transplantation: A case report

  2009influential citation
• Establishment of an acute graft-versus-host disease model following liver transplantation in donor-dominant one-way major histocompatibility complex matching rats.

  2009cites this paper
• Pathology of graft-versus-host disease in the gastrointestinal tract.

  2009cites this paper
• Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.

  2009cites this paper
• Graft versus host disease after liver transplantation – a single center experience and review of literature

  2008cites this paper
• Graft-versus-host disease after liver transplantation: successful treatment of a case.

  2008cites this paper
• Avoiding Pitfalls: What an Endoscopist Should Know in Liver Transplantation—Part II

  2008cites this paper
• The Programmed Death (PD)‐1/PD‐Ligand 1 Pathway Regulates Graft‐Versus‐Host‐Reactive CD8 T Cells After Liver Transplantation

  2008cites this paper